Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

This study has been completed.
Sponsor:
Collaborator:
Celgene Corporation
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00633945
First received: March 4, 2008
Last updated: February 18, 2011
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
No publications provided by University of Pennsylvania

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):